益气活血中药联合吉西他滨动脉灌注治疗晚期胰腺癌临床观察  

Clinical Observation on Advanced Pancreatic Cancer Treated by Yiqi Huoxue Decoction Combined with Gemcitabine Arterial Perfusion

作　　者：张青[1] 韩冬[1] 迟惠昌[1] 杨国旺[1] 赵文硕[1] 王笑民[1] 

机构地区：[1]首都医科大学附属北京中医医院,北京100010

出　　处：《中国中医药信息杂志》2008年第8期20-21,共2页Chinese Journal of Information on Traditional Chinese Medicine

摘　　要：目的观察益气活血中药配合化学药物动脉灌注治疗晚期胰腺癌的疗效。方法回顾性研究益气活血中药配合化学药物(吉西他滨+顺铂)动脉灌注治疗晚期胰腺癌43例的临床疗效及受益反应。结果患者总有效率(CR+PR)为25.6%,临床获益率(CR+PR+NC)为67.4%,并有较好的临床受益反应,主要表现在疼痛程度、生活质量水平等方面,其疼痛缓解率达74.3%。结论益气活血中药配合吉西他滨+顺铂动脉灌注治疗晚期胰腺癌疗效可靠,有较好的临床受益反应。Objective To observe the effect of Yiqi Huoxue decoction combined with chemical arterial perfusion in treating advanced pancreatic cancer. Methods Review the clinical effect and benefit response of Yiqi Huoxue decoction combined with chemicals （Gemcitabine＋PDD} arterial perfusion in treating 43 cases of advanced pancreatic cancer. Results The objective response rate （CR＋PR） in treated group was 25.6%. The clinical benefit response rate （CR＋PR＋NC） in treated group was 67,4%, and the clinical benefits were mainly in the aspects of pain extent and quality of life. The rate of relief from pain was 74.3%. Conclusion The effect of Yiqi Huoxue decoction combined with chemicals （Gemcitabine＋PDD） arterial perfusion in treating advanced pancreatic cancer was reliable, and the clinical benefit response was good.

关 键 词：益气活血中药 吉西他滨 动脉灌注 晚期胰腺癌 

分 类 号：R273.59[医药卫生—中西医结合]